HomeVXL • CVE
add
Vaxil Bio Ltd
Previous close
$0.50
Day range
$0.20 - $0.28
Year range
$0.010 - $0.28
Market cap
1.37M CAD
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 32.00K | 203.23% |
Net income | -22.00K | -184.62% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 448.00K | -52.24% |
Total assets | 733.00K | -24.90% |
Total liabilities | 17.00K | -80.00% |
Total equity | 716.00K | — |
Shares outstanding | 2.74M | — |
Price to book | 1.92 | — |
Return on assets | -10.30% | — |
Return on capital | -11.00% | — |
Cash Flow
Net change in cash
| (CAD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -22.00K | -184.62% |
Cash from operations | -84.00K | -21.74% |
Cash from investing | 0.00 | — |
Cash from financing | — | — |
Net change in cash | -87.00K | -22.54% |
Free cash flow | -85.00K | -10.93% |
About
Founded
2006
Headquarters
Website
